Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Materials Science

Background:

• Many active pharmaceutical ingredients (APIs) exhibit poor oral bioavailability due to low solubility and instability.
• Microencapsulation techniques, including cyclodextrin complexation, are crucial for improving drug properties.
• Biopharmaceutical Classification System (BCS) Class IV drugs often present bioavailability challenges.

Purpose of the Study:

• To explore the use of cyclodextrins and cyclodextrin-based materials for enhancing oral bioavailability.
• To demonstrate the stabilization of labile drugs and improvement of nutraceuticals via encapsulation.
• To discuss the synthesis and characterization of cyclodextrin derivatives and inclusion complexes.

Main Methods:

• Formation of inclusion complexes using cyclodextrins, cyclodextrin-based polymers, nanosponges, and nanofibers.
• Encapsulation of active pharmaceutical ingredients and nutraceuticals.
• Application of analytical techniques for characterization of inclusion complex formation (solution and solid-state).

Main Results:

• Cyclodextrin complexation significantly improves solubility, dissolution rate, and bioavailability of poorly soluble drugs.
• Stabilization of labile drugs and enhancement of nutraceutical absorption were achieved through encapsulation.
• Cyclodextrin-based nanofibers offer polymer-free, eco-friendly solutions for dramatic bioavailability enhancement.

Conclusions:

• Cyclodextrin-based formulations are highly effective for overcoming oral bioavailability limitations of APIs and nutraceuticals.
• Chemically modified cyclodextrins, polymers, and nanosponges represent advanced drug delivery systems.
• Accurate characterization methods are essential for verifying true inclusion complex formation.